Iguana Healthcare Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Iguana Healthcare Management’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$3.06M	Buy	60,000 +10,000	+20%	+$504K	2.01%	18
2017 Q4	$2.32M	Hold	50,000	–	–	1.51%	25
2017 Q3	$2.66M	Sell	50,000 -25,000	-33%	-$1.48M	1.45%	30
2017 Q2	$4.66M	Hold	75,000	–	–	2.63%	13
2017 Q1	$5.08M	Sell	75,000 -85,000	-53%	-$6.48M	2.51%	11
2016 Q4	$11.3M	Sell	160,000 -240,000	-60%	-$17M	6.72%	1
2016 Q3	$28.4M	Buy	400,000 +260,000	+186%	+$16.6M	5.06%	1
2016 Q2	$6.85M	Buy	140,000 +20,000	+17%	+$1.29M	2.79%	9
2016 Q1	$7.6M	Buy	120,000 +5,000	+4%	+$327K	2.78%	13
2015 Q4	$12.9M	Buy	115,000 +5,000	+5%	+$500K	4.24%	5
2015 Q3	$10.6M	Sell	110,000 -90,000	-45%	-$10.3M	4.17%	5
2015 Q2	$20.5M	Buy	200,000 +25,000	+14%	+$1.94M	6.46%	2
2015 Q1	$10.9M	Buy	175,000 +125,000	+250%	+$6.94M	4.57%	4
2014 Q4	$2.19M	Sell	50,000 -7,500	-13%	-$344K	1.06%	36
2014 Q3	$3.25M	Buy	57,500 +15,700	+38%	+$790K	1.74%	17
2014 Q2	$1.88M	Sell	41,800 -13,200	-24%	-$543K	0.88%	42
2014 Q1	$2.69M	Buy	+55,000	New	+$2.83M	1.24%	30

Other funds holding RARE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Iguana Healthcare Management's RARE Position: Q1 2018 in Review

Iguana Healthcare Management increased its Ultragenyx Pharmaceutical (RARE) stake by 20% in Q1 2018, buying an estimated $504K and bringing the position to 60,000 shares worth $3.06M. The position accounts for 2.01% of the portfolio, ranked #18.

Iguana Healthcare Management first reported a position in RARE in Q1 2014 and has held it in 17 quarters since. The position peaked at $28.4M in Q3 2016. 165 funds tracked by Wall St. Rank hold RARE as of Q1 2018.

Iguana Healthcare Management held 60,000 shares of Ultragenyx Pharmaceutical worth $3.06M as of Q1 2018.
Iguana Healthcare Management bought 10,000 Ultragenyx Pharmaceutical shares in Q1 2018, an estimated $504K.
Ultragenyx Pharmaceutical made up 2.01% of Iguana Healthcare Management's portfolio in Q1 2018, its #18 holding.
Iguana Healthcare Management first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 17 quarters since.
Iguana Healthcare Management's Ultragenyx Pharmaceutical position peaked at $28.4M in Q3 2016.
165 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.